Earnings call transcript: Northern Technologies Q3 2025 misses EPS expectations

Northern Technologies (NTIC) reported a substantial Q3 FY2025 earnings miss, posting EPS of $0.02 against a $0.18 forecast and revenue of $21.5 million below $23.2 million expectations, triggering a 1.6% pre-market stock decline and a nearly 38% drop over six months. The shortfall was attributed to increased strategic investments, particularly in the oil and gas sector, and European macroeconomic pressures, despite a 4% year-over-year revenue increase and improved gross margins. Management remains optimistic, highlighting strong performance from its China subsidiary and potential in bioplastics innovation, while projecting improved profitability in Q4 and FY2026.

Analysis

Northern Technologies (NTIC) reported a significant Q3 FY2025 earnings miss, with an EPS of $0.02, falling 88.89% short of the $0.18 consensus forecast. Revenue of $21.5 million also missed expectations, despite a 4% year-over-year increase. The market reacted negatively, with the stock declining 1.6% in pre-market trading, compounding a nearly 38% loss over the past six months. The primary driver for the sharp decline in profitability, with net income falling to $122,000 from $977,000 a year prior, was a 7.6% rise in operating expenses attributed to planned strategic investments in its ZERUST Oil and Gas division. Segment performance was mixed: the wholly-owned China subsidiary was a standout, with sales growing 27.4% to $4.5 million, while European joint venture sales fell 12.9% due to macroeconomic pressures. The core ZERUST Oil and Gas segment's quarterly sales declined 5.3%, though management points to a more favorable 15.4% growth on a trailing-twelve-month basis. Despite the earnings shortfall and weak stock performance, the company maintains a solid balance sheet with a current ratio of 2.18 and a moderate debt-to-equity ratio of 0.12, and guidance remains optimistic for improvement in Q4 and FY2026, supported by growth in China and innovation in bioplastics.

Key Decisions for Investors

• Investors should weigh the severe near-term earnings miss and margin pressure from strategic spending against management's long-term growth narrative, particularly in the oil and gas and China segments.
• Monitor the ZERUST Oil and Gas segment's sales and profitability in Q4 to validate if the 15.4% trailing-twelve-month growth can translate into consistent quarterly results and justify the increased operating expenditure.
• Given the stock may be trading below its perceived fair value, value-oriented investors could consider the current weakness an entry point, but should be cautious of significant execution risk and negative market sentiment.
• Focus on the performance of the profitable China subsidiary, which grew 27.4%, as a critical buffer against persistent weakness in European joint ventures and potential tariff headwinds for the Natur Tec bioplastics business.